Economy

Average True Range of TherapeuticsMD, Inc. (AMEX:TXMD) stands at0.46

This means that the stock's daily price swings have been more extreme in recent times compared to the past. (TXMD) to generate earnings per share of $0.42 in 2017. Beta, which measures a stock's price volatility relative to the market, provides the cleanest measure of systematic risk for a stock. Oppenheimer Holdings analyst J. Olson now forecasts that the company will post earnings of $0.04 per share for the year, down from their previous forecast of $0.10. This cross may have investors taking a second look at company shares. The return on assets stands at -66.6%, Return on Equity now is -74.2% and the Return on Investment value is -70.8%. The analysts estimated sales for the higher end at 6.22 million and lower end at 4 million. Since the start of the calendar year, company shares have performed -5.37%. The firm's revenue was down 19.7% on a year-over-year basis.

Checking on current price levels compared to prior highs and lows, we have seen that TherapeuticsMD, Inc. If you are accessing this article on another domain, it was stolen and reposted in violation of worldwide copyright & trademark law.

TherapeuticsMD, Inc. (TXMD) now the company's industry has 31.17 P/E and the sector P/E is 32.99.

Other equities analysts have also issued reports about the stock. According to today's trading volume TherapeuticsMD, Inc.is ABOVE its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days. Deutsche Bank AG began coverage on shares of TherapeuticsMD in a research report on Friday, July 21st. The company now has a consensus rating of "Buy" and a consensus target price of $15.25. Narrowing the focus to the past week, company shares are 18.18%. Stifel Nicolaus restated a "buy" rating and set a $20.00 price target on shares of TherapeuticsMD in a research report on Monday, August 21st. Finally, Zacks Investment Research upgraded shares of TherapeuticsMD from a "sell" rating to a "hold" rating in a research report on Thursday, August 10th. TherapeuticsMD presently has a consensus rating of "Buy" and an average price target of $15.25.

The company declined -2.96% and closed its last trading session at $5.74. The Stock has YTD (year to date) performance of -3.47 percent.

Among institutions that increased their positions, 11 were new positions. TherapeuticsMD, Inc.is based in Boca Raton, Florida.

The company's stock is now moving with a +ve distance from the 200 day SMA of approximately 0.52%, and has a solid year to date (YTD) performance of -3.47% which means that the stock is constantly adding to its value from the previous fiscal year end price. Carl Domino Inc acquired a new position in TherapeuticsMD in the second quarter valued at approximately $235,000. Principal Financial Group Inc. raised its stake in TherapeuticsMD by 3.9% during the second quarter. Traynor Capital Management Inc. raised its stake in TherapeuticsMD by 14.0% during the second quarter. Bamco Inc. NY now owns 850,000 shares of the company's stock valued at $4,479,000 after buying an additional 475,200 shares during the period.

The company now has an insider ownership of 20.59 Percent and Institutional ownership of 73.8 Percent. The stock traded within a range of $5.30 and $6.09. The stock was acquired at an average price of $5.99 per share, for a total transaction of $29,950.00. (:TXMD)'s stock has been -3.53%. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.



Like this

Latest


09 November 2017
OH voters reject Issue 2, battle over prescription drug prices
Vote "no" on Issue 2? As precincts continued to report, Issue 2 continued to show its unpopularity. Drug price legislation was defeated in Ohio Tuesday, according to STAT .

09 November 2017
Paul Merson reckons Diego Simeone would want the Everton job
However, with Ronald Koeman fired, the club is now being managed by caretaker manager David Unsworth but need someone permanent. Everton has collected just 11 points in their 11 EPL games as they sit 15 in the standings, just 2 points clear of relegation.

09 November 2017
Imran Khan visits Chitral, announces new district
In his address in Chitral, the Chairman PTI said that the government's responsibility is to provide facilities to people. Chairman PTI Imran Khan and Chief Minister KP Pervez Khattak announced a new district for Chitral.

09 November 2017
WWE NXT Results 11/8 Roderick Strong vs Adam Cole & More!
Cole hits a superkick into an ushigaroshi for a near fall before Strong hits a jumping knee that almost knocks Cole out. Strong had the advantage before Cole used the referee as a shield and nailed Strong with a superkick to take over.

09 November 2017
$5.6 Trillion: Cost of the US Wars in The Middle East & Asia
Moreover, the study notes that spending on veterans benefits has increased by almost $300 billion since 2001 due to those wars. Adding likely costs for FY2018 and estimated future spending on veterans, the costs of war total more than $5.6 trillion.

09 November 2017
Dragic scores 29, leads Heat past Suns
While Winslow did have a solid showing on Monday against the Warriors, it's still tough to buy this uptick. Monroe will join a big-man crew that includes starting center Tyson Chandler and reserve Alex Len.

09 November 2017
Kevin Mirallas apologises after Everton training ground wobbler
Baines, scorer of the decisive goal against the Hornets, told evertontv when asked about winning for Unsworth: "It makes it extra special".

09 November 2017
Stock Repurchase Plan Announced by Alcentra Capital Corp. (ABDC) Board of Directors
Inc. now owns 12,448 shares of the company's stock worth $162,000 after buying an additional 268 shares during the last quarter. Following the completion of the transaction, the insider now owns 4,600 shares in the company, valued at approximately $59,248.

09 November 2017
Stalin to lead Demon Black day protests
DMK men wore black shirts, while women supporters, besides leaders like Kanimozhi, were dressed in black sarees. The note ban decision was "unexpected", he said.

09 November 2017
Tesaro, Inc. (NASDAQ:TSRO) Buckles Under The Trend Lines
ValuEngine downgraded TESARO from a hold rating to a sell rating in a research report on Monday, July 17th. Fmr Limited Liability Co holds 0.13% of its portfolio in TESARO Inc (NASDAQ:TSRO) for 7.70 million shares.



Recommended